首页> 美国卫生研究院文献>International Journal of Environmental Research and Public Health >Remarkable Reduction of Cocaine Use in Dual Disorder (Adult Attention Deficit Hyperactive Disorder/Cocaine Use Disorder) Patients Treated with Medications for ADHD
【2h】

Remarkable Reduction of Cocaine Use in Dual Disorder (Adult Attention Deficit Hyperactive Disorder/Cocaine Use Disorder) Patients Treated with Medications for ADHD

机译:在患有ADHD的药物治疗的双重障碍(成人注意力缺陷多动症/可卡因使用障碍)患者中可卡因使用量显着减少

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

: Cocaine use disorder (CUD) is a growing public health concern, but so far no effective pharmacotherapies have been demonstrated. Stimulant medications have proved to be promising in CUD treatment. The self-medication hypothesis (SMH) can help to explain this phenomenon better, especially in cases where CUD co-occurs with adult attention deficit hyperactivity disorder (A-ADHD). : In the present retrospective study, a sample of 20 consecutive patients (aged from 18 to 65 years) with dual disorder (A-ADHD/CUD), under treatment with methylphenidate (MPH) or atomoxetine (ATM) medications, was followed to study the effects of A-ADHD treatment on cocaine use. Patients were followed for a mean period of 7 months (minimum 1, maximum 30 months). All individuals were assessed with standardized questionnaires to evaluate diagnosis, treatment efficacy, and clinical improvement. : the results showed that behaviors reflecting cocaine addiction were sharply reduced during the stimulant treatment of A-ADHD, and were not correlated with age, gender, familiarity, length of treatment, or medication used. CUD improvement was closely correlated with the A-ADHD improvement. This study supports the validity of the SMH in ADHD patients with co-occurring CUD.
机译::可卡因使用障碍(CUD)是引起公众日益关注的公共卫生问题,但迄今为止尚未证明有效的药物治疗方法。刺激药物已被证明在CUD治疗中很有前途。自我用药假说(SMH)可以帮助更好地解释这一现象,特别是在CUD与成人注意缺陷多动障碍(A-ADHD)并发的情况下。 :在本回顾性研究中,随访了接受哌醋甲酯(MPH)或阿莫西汀(ATM)药物治疗的20例双重疾病(A-ADHD / CUD)连续患者(年龄从18至65岁)的样本A-ADHD治疗对可卡因使用的影响。随访患者平均7个月(最少1个月,最多30个月)。所有患者均通过标准化问卷进行评估,以评估诊断,治疗效果和临床改善。 :结果表明,在对A-ADHD进行兴奋性治疗期间,反映可卡因成瘾的行为急剧减少,与年龄,性别,熟悉程度,治疗时间或所用药物无关。 CUD的改善与A-ADHD的改善密切相关。这项研究支持SMH在伴发CUD的ADHD患者中的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号